Signaling Pathways and Rationale for Molecular Therapies in Hepatocellular Carcinoma

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Original languageEnglish
Title of host publicationMalignant Liver Tumors
Subtitle of host publicationCurrent and Emerging Therapies: Third Edition
PublisherWiley-Blackwell
Pages368-381
Number of pages14
ISBN (Electronic)9781444317053
ISBN (Print)9781405179768
DOIs
StatePublished - 9 Dec 2009

Keywords

  • BCLC (Barcelona Clinic Liver Cancer)
  • Comparative genomic hybridization (CGH)
  • Epidermal growth factor receptor (EGFR)
  • European Medicines Agency (EMEA)
  • Hepatocellular carcinoma (HCC)
  • Hepatocyte growth factor (HGF)
  • Transarterial chemoembolization [TACE]
  • Tyrosine kinase receptors (TKRs)

Cite this